Drug General Information
Drug ID
D03TFP
Former ID
DNC011073
Drug Name
KNI-10758
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531036]
Structure
Download
2D MOL

3D MOL

Formula
C41H55N5O6S
Canonical SMILES
CCNCCN(CC)C1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=<br />O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C
InChI
1S/C41H55N5O6S/c1-7-42-18-19-45(8-2)30-20-26(3)37(27(4)21-30)52-24-34(48)43-32(22-28-14-10-9-11-15-28)36(49)40(51)46-25-53-41(5,6)38(46)39(50)44-35-31-17-13-12-16-29(31)23-33(35)47/h9-17,20-21,32-33,35-36,38,42,47,49H,7-8,18-19,22-25H2,1-6H3,(H,43,48)(H,44,50)/t32-,33+,35-,36-,38+/m0/s1
InChIKey
TYAUZZDMTCDBHN-CTRNRRKFSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [531036]
References
Ref 531036Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9. Epub 2010 Jun 25.Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
Ref 531036Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9. Epub 2010 Jun 25.Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.